- Editor
- 29 May 2023
US study finds 1 in 10 get long COVID after omicron, starts identifying key symptoms
About 10% of people appear to suffer long COVID after an omicron infection, a lower estimate than earlier in the pandemic, according to a study
About 10% of people appear to suffer long COVID after an omicron infection, a lower estimate than earlier in the pandemic, according to a study
With researchers reporting high rates of anxiety and depression, calls are growing to fundamentally change science before it’s too late. There is a mental-health crisis
Se llama ‘pangenoma’, y podría explicar el ADN que nos hace únicos a cada uno de nosotros Lo gracioso sobre el Proyecto Genoma Humano es
El sistema capta el sentido de las frases más que su literalidad gracias a la inteligencia artificial A tres sujetos les hicieron oír un podcast
Un estudio reveló que los hombres y las personas que sufrieron la enfermedad de forma grave tenían más probabilidades de desarrollar la afección en el
Synthetic embryos made without eggs and sperm are looking increasingly like the real thing—raising thorny ethical questions. Embryos are special. These tiny blobs of cells
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out. When a startup called
Para ciertas personas, la preparación para la universidad puede comenzar en un tubo de ensayo, y eso preocupa mucho a los especialistas en ética Imagínese
The material can be injected intravenously and has potential application in heart attacks, traumatic brain injury and more A new biomaterial that can be injected
Venture capital firm Advent France Biotechnology led fundraising, alongside Crédit Mutuel Innovation and Pierre FabreCo-founded by AFB and leading cancer institutes Gustave Roussy and Institut